BRIEF published on 03/26/2026 at 07:34, 7 months 9 days ago DEUTZ prévoit une forte croissance malgré un contexte de marché difficile en 2025 Croissance Des Revenus Transformation Stratégique DEUTZ AG Programme De Réduction Des Coûts Résultats Annuels 2025
BRIEF published on 03/26/2026 at 07:32, 7 months 9 days ago Delivery Hero's Adj. EBITDA Rises by 30% Amid Strategic Adjustments Free Cash Flow EBITDA Growth Quick Commerce Taiwan Asset Sale Everyday App Strategy
BRIEF published on 03/26/2026 at 07:32, 7 months 9 days ago L'EBITDA ajusté de Delivery Hero progresse de 30 % grâce à des ajustements stratégiques. Flux De Trésorerie Disponible Croissance De L'EBITDA Commerce Rapide Vente D'actifs Taïwanais Stratégie D'application Quotidienne
BRIEF published on 03/26/2026 at 07:16, 7 months 9 days ago Berentzen-Gruppe Reports 2025 Results with Significant Profit Dividend Proposal Berentzen Group Profit Report 2026 Outlook 2025 Financial Results
BRIEF published on 03/26/2026 at 07:16, 7 months 9 days ago Berentzen-Gruppe annonce des résultats 2025 avec un bénéfice significatif Proposition De Dividende Groupe Berentzen Rapport Sur Les Bénéfices Résultats Financiers 2025 Perspectives 2026
BRIEF published on 03/26/2026 at 07:12, 7 months 9 days ago Heidelberg Pharma Publishes 2025 Financial Results and 2026 Outlook Financial Results Cost-cutting Measures Heidelberg Pharma ADC Technology 2026 Outlook
BRIEF published on 03/26/2026 at 07:12, 7 months 9 days ago Heidelberg Pharma publie ses résultats financiers pour 2025 et ses perspectives pour 2026. Résultats Financiers Heidelberg Pharma Mesures De Réduction Des Coûts Technologie ADC Perspectives 2026
BRIEF published on 03/26/2026 at 07:10, 7 months 9 days ago Swissmedic Approves PEDMARQSI® for Preventing Hearing Loss in Children Swissmedic Approval Norgine PEDMARQSI® Children's Hearing Loss Cisplatin Chemotherapy
BRIEF published on 03/26/2026 at 07:10, 7 months 9 days ago Swissmedic approuve PEDMARQSI® pour la prévention de la perte auditive chez l'enfant Norgine PEDMARQSI® Approbation Swissmedic Perte Auditive Chez L'enfant Chimiothérapie Au Cisplatine
BRIEF published on 03/26/2026 at 07:10, 7 months 9 days ago EDAG Group Faces Challenges and Implements Strategic Measures for Growth EDAG Engineering Strategic Diversification Automotive Challenges 2025 Financial Results Defense Sector Growth
Published on 11/04/2026 at 23:10, 3 hours 25 minutes ago Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Published on 11/04/2026 at 23:00, 3 hours 35 minutes ago Viemed Healthcare Announces Third Quarter 2026 Financial Results
Published on 11/04/2026 at 22:15, 4 hours 20 minutes ago Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Published on 11/04/2026 at 22:05, 4 hours 30 minutes ago Stabilis Solutions Announces Third Quarter 2026 Results
Published on 11/05/2026 at 00:02, 2 hours 32 minutes ago EQS-Adhoc: NEXTDC Limited: Response to Share Raid by Goodman Group and Digital Realty
Published on 11/04/2026 at 19:41, 6 hours 54 minutes ago EQS-Adhoc: SNP SE Raises Outlook for the Full Year 2026
Published on 11/04/2026 at 19:25, 7 hours 10 minutes ago Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory Aggressive B-cell non-Hodgkin Lymphoma at the 2026 ASH Annual Meeting
Published on 11/04/2026 at 18:43, 7 hours 52 minutes ago EQS-Adhoc: Deutsche EuroShop refines its revenue forecast and raises its earnings forecast for the 2026 financial year
Published on 11/04/2026 at 18:05, 8 hours 30 minutes ago Redis Expands Redis Iris to Give AI Agents the Memory, Context, and Messaging They Need to get to Production
Published on 11/04/2026 at 18:00, 8 hours 35 minutes ago The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026
Published on 11/04/2026 at 18:00, 8 hours 35 minutes ago L’État belge et le groupe ENGIE ont convenu de se donner un délai supplémentaire jusqu’au 12 décembre 2026 pour la conclusion des Heads of Terms
Published on 11/04/2026 at 17:44, 8 hours 51 minutes ago Aéroports de Paris SA - Information regarding the voting rights and shares as of 31 October 2026
